2nd Annual Clinical Trials Series 2026

2nd Annual Clinical Trials Series 2026 is organized by Virtue Insight and will be held on Sep 24, 2026 at Sterlings Mac Hotel, Bengaluru, Karnataka, India.

Description:
The global clinical trial outsourcing market continues to expand rapidly, with recent estimates valuing it at over USD 55 billion in 2024 and projecting it to surpass USD 115 billion by 2032, driven by a CAGR of around 9%. This growth is being shaped by a new era of innovation—where artificial intelligence, decentralized and hybrid trial models, and digital health technologies are transforming how clinical research is designed, conducted, and delivered.

AI is accelerating patient recruitment, optimizing trial design, and enhancing data analysis, while decentralized trials are improving accessibility, patient engagement, and real-world evidence generation. At the same time, the integration of digital health tools—from wearable devices to remote monitoring platforms—is enabling more efficient, patient-centric, and data-driven studies.

In this rapidly evolving landscape, the 2nd Annual Clinical Trials Series 2026 provides a vital platform to bring together industry leaders, including sponsors, CROs, regulators, technology innovators, and research institutions. This forum aims to foster collaboration, share strategic insights, and explore how emerging technologies can address growing complexities while maintaining quality, compliance, and patient focus.

As clinical trials become more digitally enabled and globally connected, it is essential to embrace innovation and build agile, future-ready strategies. We are honored to welcome you to this summit and look forward to meaningful discussions that will help shape a more efficient, inclusive, and patient-centric clinical research ecosystem. We wish and pray that all our efforts will be beneficial to our industries and to our country at large

Key Areas:

• Clinical Trials - Market Analysis -Opportunities & Challenges
• Decentralised Clinical Trials (DCTs) / Patients Prioritised Trials
• Sponsor / Site / CRO/ Patients / Regulators
• Clinical Trial Supply -What's the new way forward?
• Clinical Trial Design/ Clinical Trail Management
• Outsourcing /Partnerships / RBQM
• Inspection Readiness /Site Management /Risk Monitoring
• Technology & Innovation / RWE & RWD
• Key Regulatory Changes & Developments

Key Speakers:

• RAMESH JAGANNATHAN, VP Clinical Research & PV, Bharat Serums and Vaccines
• SHUBHADEEP SINHA, Senior Vice-President & Medical Director, Hetero Group
• PRATIK SHAH, Vice President - Medical Affairs, Bharat Serums and Vaccines
• SURAJ RAVINDRAN, Senior Director, Head of Global CDM, Service Delivery, GSK
• VIJAY PARTHASARATHY, Senior Director, Clinical Operations, Novo Nordisk
• KRISHNENDU SENGUPTA, Director - Centralized Monitoring, AstraZeneca
• MILIND ANTANI, Leader, Pharma and Healthcare, Nishith Desai Associates
• VAIBHAV SALVI, Director and Head – Clinical Study Unit, India and South East Asia, Sanofi
• MOHAMMED IQBAL, Director Product Strategy & Innovation, GSK
• ARPIT SHAH, Director & Head, Medical Writing Operations, Worldwide Clinical Trials
• NISIN C.R Team Head-Associate Director CTSM Novartis
• KHALEEL AHMAD, Associate Director, Line Manager, Global Trial Management, Bristol Myers Squibb
• MANSOOR NALAKATH, Associate Director - eCOA Programming, Eli Lilly and Company
• VISHIKA HEGDE, Associate Director - Data Governance Standards & Quality, GSK
• SOUVIK CHATTERJEE, Associate Director, R&D Quality Lead, Bristol Myers Squibb
• JEGAN JAYABALAN, Senior Director, Recipharm
• HITENDRA NATH PANDEY, Director – Statistics, Eli Lilly and Company
• UME ASMA, Associate Director- Global Covid, Vaccine Safety Trial, Pfizer
• RENUKA NEOGI, Deputy GM & Head - Global Clinical Quality Management, Sun Pharm
• ASWIN KUMAR, Head Global Medical Writing, Viatris
• SWEETY MATHEW, Global RA CMC Lead/ Senior Regulatory Professional, Novo Nordisk
• SAJJAD PATIL, Therapeutic Area Head - Clinical Operations, Biocon Biologics
• NEELAKANT KRISHNAN, Senior GM - Global Trial Management, Sun Pharma
• RAHUL RATHOD, Former Director Medical Affairs, AbbVie
• TANVEER MUBASHIR, Clinical Development Operations Strategy, lead India and APAC, Takeda
• PRASHANT MEHROTRA, Sr. GM Clinical Research, Bharat Serums and Vaccines
• KAVITA LAMROR, Former Partner, RWE & Digital Transformation, Maxis Clinical